Cadrenal Therapeutics, Inc. (CVKD)
NASDAQ: CVKD · Real-Time Price · USD
13.81
-1.38 (-9.08%)
Dec 3, 2024, 12:14 PM EST - Market open
Cadrenal Therapeutics Market Cap
Cadrenal Therapeutics has a market cap or net worth of $24.62 million as of December 3, 2024. Its market cap has increased by 319.12% in one year.
Market Cap
24.62M
Enterprise Value
22.71M
1-Year Change
319.12%
Ranking
Category
Stock Price
$13.81
Market Cap Chart
Since the IPO on January 20, 2023, Cadrenal Therapeutics's market cap has decreased from $58.17M to $24.62M, a decrease of -57.68%. That is a compound annual growth rate of -36.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 2, 2024 | 27.08M | 181.00% |
| Dec 29, 2023 | 9.64M | -83.44% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| DURECT | 28.56M |
| VSee Health | 28.35M |
| CytoMed Therapeutics | 27.97M |
| NeurAxis | 27.88M |
| IGC Pharma | 27.65M |
| CERo Therapeutics Holdings | 26.70M |
| IN8bio | 26.67M |
| BioLineRx | 26.39M |